<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35416104</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1365-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine</Title>
          <ISOAbbreviation>Ann Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.</ArticleTitle>
        <Pagination>
          <StartPage>962</StartPage>
          <EndPage>976</EndPage>
          <MedlinePgn>962-976</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2046289</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Primary lymphoma of the female genital tract (PLFGT) is a sporadic extranodal lymphoma. Its epidemiology and prognosis are not fully recognized. Our study aimed to construct and validate prognostic nomograms for predicting survival for patients with PLFGT.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Incidence rate from 1975 to 2017 and patients with PLFGT from 1975 to 2011 in the Surveillance, Epidemiology and End Results (SEER) database were retrospectively reviewed. The nomograms of overall survival (OS) and disease-specific survival (DSS) were established according to the multivariate Cox regression analyses. The concordance index (C-index) and calibration plots were used to demonstrate its robustness and accuracy.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 617 PLFGT patients were identified. The overall incidence of PLFGT is 0.437/1,000,000 (adjusted to the US standard population in 2000) from 1975 to 2017. Age, histological subtype, Ann Arbor Stage, and therapeutic strategy were identified as independent prognostic factors for OS and DSS by multivariate Cox regression (<i>p</i> &lt; .05). Nomograms to predict 1-, 5-, and 10-year OS and DSS were established. The C-index and calibration plots showed a good discriminative ability and an optimal accuracy of the nomograms. Patients were divided into three risk groups according to the model of OS.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The incidence of PLFGT has increased in the past 40 years, and the nomograms were developed and validated as an individualized tool to predict OS and DSS for all PLFGT patients and DLBCL patients. All patients are divided into three risk groups to assist clinicians to identify patients at high-risk and choose the optimal individualized treatments for patients.HighlightsThe incident of PLFGT and its subtypes were calculated and compared.Nomograms were constructed to predict the 1-, 5-, and 10-year OS and DSS.Patients are divided into the low-risk, medium-risk, and high-risk according total score of the nomogram.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peng</LastName>
            <ForeName>Fei</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Jingwen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mu</LastName>
            <ForeName>Shidai</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>You</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Jiewen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ai</LastName>
            <ForeName>Lisha</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med</MedlineTA>
        <NlmUniqueID>8906388</NlmUniqueID>
        <ISSNLinking>0785-3890</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005836" MajorTopicYN="N">Genitalia, Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008223" MajorTopicYN="Y">Lymphoma</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049451" MajorTopicYN="Y">Nomograms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018426" MajorTopicYN="N">SEER Program</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Primary lymphoma</Keyword>
        <Keyword MajorTopicYN="N">SEER</Keyword>
        <Keyword MajorTopicYN="N">female genital tract</Keyword>
        <Keyword MajorTopicYN="N">incidence</Keyword>
        <Keyword MajorTopicYN="N">nomogram</Keyword>
        <Keyword MajorTopicYN="N">prognosis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>8</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35416104</ArticleId>
        <ArticleId IdType="pmc">PMC9009932</ArticleId>
        <ArticleId IdType="doi">10.1080/07853890.2022.2046289</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Zelenetz AD, Gordon LI, Wierda WG, et al. . 
Non-Hodgkin's lymphomas, version 2.2014. J Natl Compr Canc Netw. 2014; 12(6):916–946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24925202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krol AD, Le Cessie S, Snijder S, et al. . 
Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol. 2003; 14(1):131–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12488305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanley KZ, Tadros TS, Briones AJ, et al. . 
Hematologic malignancies of the female genital tract diagnosed on liquid-based Pap test: Cytomorphologic features and review of differential diagnoses. Diagn Cytopathol. 2009; 37(1):61–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18973127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merritt AJ, Shenjere P, Menasce LP, et al. . 
Primary extranodal marginal zone B cell lymphoma of the uterus: a case study and review of the literature. J Clin Pathol. 2014; 67(4):375–377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24352894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Binesh F, Karimi Zarchi M, Vahedian H, et al. . 
Primary malignant lymphoma of the uterine cervix. BMJ Case Rep. 2012; 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4544082</ArticleId>
            <ArticleId IdType="pubmed">23008373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guastafierro S, Tedeschi A, Criscuolo C, et al. . 
Primary extranodal non-Hodgkin’s lymphoma of the vagina: a case report and a review of the literature. Acta Haematol. 2012; 128(1):33–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22584110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kosari F, Daneshbod Y, Parwaresch R, et al. . 
Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol. 2005; 29(11):1512–1520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16224219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cubo AM, Soto ZM, Cruz M, et al. . 
Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: a case report. Medicine (Baltimore). 2017; 96(19):e6846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5428606</ArticleId>
            <ArticleId IdType="pubmed">28489772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Hamele-Bena D, Fai Chow K, et al. . 
B-cell lymphoma of the vagina occurring after treatment for classic Hodgkin lymphoma: a case report and literature review. Diagn Cytopathol. 2013; 41(5):463–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21953901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lagoo AS, Robboy SJ.. 
Lymphoma of the female genital tract: current status. Int J Gynecol Pathol. 2006; 25(1):1–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16306779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perren T, Farrant M, McCarthy K, et al. . 
Lymphomas of the cervix and upper vagina: a report of five cases and a review of the literature. Gynecol Oncol. 1992; 44(1):87–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1730432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trenhaile TR, Killackey MA.. 
Primary pelvic non-Hodgkin's lymphoma. Obstet Gynecol. 2001; 97(5 Pt 1):717–720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11339922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng F, Li J, Mu S, et al. . 
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival. Breast. 2021; 57:49–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8027901</ArticleId>
            <ArticleId IdType="pubmed">33774459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gleeson JP, Woods GB, Watson GA, et al. . 
Synchronous diffuse large B cell lymphomas of the endometrium and breast: a staging dilemma. Ir J Med Sci. 2017; 186(4):867–873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28470353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vijayakumar S, Serur E, Bybordi B, et al. . 
Primary gynecological non-Hodgkin's lymphoma: a differential diagnosis of a pelvic mass. Gynecol Oncol Rep. 2016; 18:29–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5090195</ArticleId>
            <ArticleId IdType="pubmed">27822491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmad AK, Hui P, Litkouhi B, et al. . 
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience. Int J Gynecol Cancer. 2014; 24(7):1250–1255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8139417</ArticleId>
            <ArticleId IdType="pubmed">25010039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szánthó A, Bálega JJ, Csapó Z, et al. . 
Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report. Gynecol Oncol. 2003; 89(1):171–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12694673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh L, Madan R, Benson R, et al. . 
Primary non-Hodgkins lymphoma of uterine cervix: a case report of two patients. J Obstet Gynaecol India. 2016; 66(2):125–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4818829</ArticleId>
            <ArticleId IdType="pubmed">27046968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anagnostopoulos A, Mouzakiti N, Ruthven S, et al. . 
Primary cervical and uterine corpus lymphoma; a case report and literature review. Int J Clin Exp Med. 2013; 6(4):298–306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3631556</ArticleId>
            <ArticleId IdType="pubmed">23641308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onyiuke I, Kirby AB, McCarthy S.. 
Primary gynecologic lymphoma: imaging findings. AJR Am J Roentgenol. 2013; 201(4):W648–655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24059405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salem U, Menias CO, Shaaban A, et al. . 
Hematopoietic tumors of the female genital system: imaging features with pathologic correlation. Abdom Imaging. 2014; 39(4):922–934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24590396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vang R, Medeiros LJ, Silva EG, et al. . 
Non-Hodgkin's lymphoma involving the vagina: a clinicopathologic analysis of 14 patients. Am J Surg Pathol. 2000; 24(5):719–725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10800991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vang R, Medeiros LJ, Malpica A, et al. . 
Non-Hodgkin's lymphoma involving the vulva. Int J Gynecol Pathol. 2000; 19(3):236–242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10907172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vang R, Silva EG, Medeiros LJ, et al. . 
Endometrial carcinoma and non-Hodgkin's lymphoma involving the female genital tract: a report of three cases. Int J Gynecol Pathol. 2000; 19(2):133–138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10782409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris NL, Scully RE.. 
Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer. 1984; 53(11):2530–2545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6585265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carr I, Hill AS, Hancock B, et al. . 
Malignant lymphoma of the cervix uteri: histology and ultrastructure. J Clin Pathol. 1976; 29(8):680–686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC476146</ArticleId>
            <ArticleId IdType="pubmed">783205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vang R, Medeiros LJ, Warnke RA, et al. . 
Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases. Mod Pathol. 2001; 14(11):1093–1099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11706069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan WA, Deshpande KA, Kurdukar M, et al. . 
Primary Burkitt's lymphoma of endometrium and bilateral ovaries in a 6-year-old female: report of a rare entity and review of the published work. J Obstet Gynaecol Res. 2013; 39(10):1484–1487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23855432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Signorelli M, Maneo A, Cammarota S, et al. . 
Conservative management in primary genital lymphomas: the role of chemotherapy. Gynecol Oncol. 2007; 104(2):416–421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17049970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muntz HG, Ferry JA, Flynn D, Fuller
AF, Jr, et al. . 
Stage IE primary malignant lymphomas of the uterine cervix. Cancer. 1991;68(9):2023–2032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1913551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hariprasad R, Kumar L, Bhatla DM, et al. . 
Primary uterine lymphoma: report of 2 cases and review of literature. Am J Obstet Gynecol. 2006; 195(1):308–313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16813759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vang R, Medeiros LJ, Fuller GN, et al. . 
Non-Hodgkin's lymphoma involving the gynecologic tract: a review of 88 cases. Adv Anat Pathol. 2001; 8(4):200–217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11444509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heredia F, Bravo M, Pierotic M, et al. . 
Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix. Gynecol Oncol. 2005; 97(1):285–287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15790479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaplan EJ.
Commenting on “HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma” by Pham et al. 90:204-6. Gynecol Oncol. 2004; 93(3):719–720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15196875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan SS, Peng XC, Cao Y.. 
Primary precursor B cell lymphoblastic lymphoma of uterine corpus: case report and review of the literature. Arch Gynecol Obstet. 2011; 284(5):1289–1292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21193918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balachandran VP, Gonen M, Smith JJ, et al. . 
Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015; 16(4):e173–e180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4465353</ArticleId>
            <ArticleId IdType="pubmed">25846097</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
